Vaccines. Recombinant poxvirus vaccines are worthy candidates given the wealth of experience using vaccinia for smallpox immunization programs in humans, and the development of recombinant techniques that enable insertion of substantial lengths of foreign DNA [1?]. More recently, attenuated strains of vaccinia have been developed (modified vaccinia Ankara; MVA) that are safer for use in young or i
Vaccines. Recombinant poxvirus vaccines are worthy candidates given the wealth of experience using vaccinia for smallpox immunization programs in humans, and the development of recombinant techniques that enable insertion of substantial lengths of foreign DNA [1?]. More recently, attenuated strains of vaccinia have been developed (modified vaccinia Ankara; MVA) that are safer for use in young or i
Tsuda M, Suzuki H, Saitoh HA (2002) Immunohistochemical recognition of human follicular dendritic cells (FDCs) in routinely processed paraffin sections. J Histochem Cytochem 50: 1475?486. 27. Haynes BF, Heinly CS (1995) Early human T cell development: analysis of the human thymus at the time of initial entry of hematopoietic stem cells into the fetal thymic microenvironment. J Exp Med 181: 1445?45
Ly at doses of 5 ?108 pfu each. Clinical monitoring for symptoms took place for one hour, and symptom diaries were kept for one week following each immunization. All toxicities noted during the study were classified by the DAIDS Toxicity Table for Grading Severity of Adult Adverse Experiences? dated August, 1992, and a protocol specific Supplemental Toxicity Table for reactogenicity occurring with
Vaccines. Recombinant poxvirus vaccines are worthy candidates given the wealth of experience using vaccinia for smallpox immunization programs in humans, and the development of recombinant techniques that enable insertion of substantial lengths of foreign DNA [1?]. More recently, attenuated strains of vaccinia have been developed (modified vaccinia Ankara; MVA) that are safer for use in young or i
Ministered to HIV-infected young adults on highly active antiretroviral therapy (HAART).NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript2.2. Vaccine2. Materials and methodsThis was a prospective, multicenter trial carried out by the Pediatric AIDS Clinical Trials Group (PACTG) and the International Maternal, Pediatric, Adolescent, AIDS Clinical Trials (IMPAACT) network. T
Tance use), and immunologic measures in plasma and CSF. 2. Materials and methods Northwestern University Institutional Review Board approved this investigation, which was conducted in compliance with U.S. federalhttp://dx.doi.org/10.1016/j.nicl.2015.07.012 2213-1582/?2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.or
Tance use), and immunologic measures in plasma and CSF. 2. Materials and methods Northwestern University Institutional Review Board approved this investigation, which was conducted in compliance with U.S. federalhttp://dx.doi.org/10.1016/j.nicl.2015.07.012 2213-1582/?2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.or